VAERS reports by lot

Moderna COVID-19 lot 018F21A: VAERS reports

181 VAERS reports list lot 018F21A as a Moderna COVID-19 vaccine, received between 2021-11-13 and 2024-04-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
181
Reports
20%
Marked serious
5
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)11221%
Neurological10319%
Gastrointestinal6512%
Cardiac / Cardiovascular5711%
Musculoskeletal377%
Respiratory367%
Injection-site / Local reaction357%
Allergic / Anaphylactic306%
Dermatological (non-injection-site)295%
Psychiatric / Neuropsychiatric143%
Reproductive / Menstrual71%
Thrombotic / Hematological41%
Autoimmune / Immune-mediated31%

Where reports came from

U.S. state of the reporter, where given (top 12).

California37
Kentucky14
North Carolina9
Minnesota8
Texas8
Missouri7
Colorado6
Illinois6
Massachusetts6
Wisconsin5
Oregon4
Florida3

Reports by month received

2021-1130
2021-1249
2022-0117
2022-0217
2022-038
2022-043
2022-0510
2022-0624
2022-072
2022-082
2022-093
2022-101
2022-111
2022-125
2023-021
2023-031
2023-042
2023-051
2023-071
2023-082
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.